This activation leads to an increase in the production of IFN-γ and Granzyme B.111This study proposes a hypothesis that the gut microbiota, beyond its known indirect effects on immune responses and effectiveness of immunotherapy, can directly impact tumor immunity and responses to ICI therapies by translocating into the tumor microenvironment. The gene discussed is IFNG; the disease is neoplasm.